Global Chronic Pain Extracorporeal Shock Wave Therapy Device Market Strategic Research Report
By Type: Electromagnetic ESWT Device, Electrohydraulic ESWT Device, Piezoelectric ESWT Device, Pneumatic/Radial Pressure Wave Device
By Application: Rehabilitation Department, Pain Clinic, Sports Medicine Institution, Physiotherapy Center, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Enovis, BTL Industries, EMS DolorClast, Zimmer MedizinSysteme, STORZ MEDICAL, Richard Wolf, Gymna, ASTAR, Likamed GmbH, İnceler Medikal, MTS Medical, SoftWave TRT, Longest Medical, WIKKON
Visão geral
Scope of the Report
The global Chronic Pain Extracorporeal Shock Wave Therapy Device market size is predicted to grow from US$ 458 million in 2025 to US$ 760 million in 2032; it is expected to grow at a CAGR of 7.5% from 2026 to 2032.
In 2025, global Chronic Pain Extracorporeal Shock Wave Therapy Device production reached approximately 18,200 units, with an average global market price of around 25,700 US$/unit.
Chronic Pain Extracorporeal Shock Wave Therapy Device is a non-invasive physical rehabilitation medical device that generates focused or radial extracorporeal shock waves to act on human soft tissues, joints and muscle attachment points. It can improve local blood circulation, relieve tissue adhesion, ease inflammatory reaction and accelerate tissue repair, so as to effectively alleviate various chronic musculoskeletal pains without surgery or drug intervention. Safe and easy to operate, it is widely applied in rehabilitation departments, pain clinics, sports medicine institutions and physical therapy centers for relieving joint pain, fasciitis and soft tissue strain pain.
Rising sub-health population, increasing number of people suffering from chronic muscle and joint pain, and the popularization of non-invasive physical therapy continuously boost market demand for this therapy device. The development of sports rehabilitation and community medical care further expands market space. Business opportunities lie in optimizing shock wave energy regulation and precise positioning technology, developing portable household and professional medical grade differentiated products, simplifying operation procedures, matching standardized treatment courses, and expanding sales channels in rehabilitation institutions and offline health care institutions to occupy more shares in physical pain relief equipment market.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Chronic Pain Extracorporeal Shock Wave Therapy Device market?
What factors are driving Chronic Pain Extracorporeal Shock Wave Therapy Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chronic Pain Extracorporeal Shock Wave Therapy Device market opportunities vary by end market size?
How does Chronic Pain Extracorporeal Shock Wave Therapy Device break out by Shock Wave Generation Technology, by Application?
This report presents a comprehensive overview of the global Chronic Pain Extracorporeal Shock Wave Therapy Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Shock Wave Generation Technology
- Electromagnetic ESWT Device
- Electrohydraulic ESWT Device
- Piezoelectric ESWT Device
- Pneumatic/Radial Pressure Wave Device
Segment by Focusing Mode
- Focused Shock Wave Therapy Device
- Radial Shock Wave Therapy Device
- Defocused/Broad-Focus Shock Wave Therapy Device
- Combined Focused + Radial Shock Wave Therapy Device
Segment by Energy Flux Density
- Low-Energy ESWT Device: <0.08 mJ/mm²
- Medium-Energy ESWT Device: 0.08–0.28 mJ/mm²
- High-Energy ESWT Device: >0.28 mJ/mm²
Segment by Application
- Rehabilitation Department
- Pain Clinic
- Sports Medicine Institution
- Physiotherapy Center
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Chronic Pain Extracorporeal Shock Wave Therapy Device market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Rehabilitation Department, Pain Clinic, Sports Medicine Institution evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Chronic Pain Extracorporeal Shock Wave Therapy Device Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Electromagnetic ESWT Device
- 3.1.3 Electrohydraulic ESWT Device
- 3.1.4 Piezoelectric ESWT Device
- 3.1.5 Pneumatic/Radial Pressure Wave Device
- 3.1.6 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Rehabilitation Department
- 4.1.3 Pain Clinic
- 4.1.4 Sports Medicine Institution
- 4.1.5 Physiotherapy Center
- 4.1.6 Others
- 4.1.7 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Enovis
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 BTL Industries
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 EMS DolorClast
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Zimmer MedizinSysteme
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 STORZ MEDICAL
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Richard Wolf
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Gymna
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 ASTAR
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Likamed GmbH
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 İnceler Medikal
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 MTS Medical
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 SoftWave TRT
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Longest Medical
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 WIKKON
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
How big is the global Chronic Pain Extracorporeal Shock Wave Therapy Device market?
How fast is the Chronic Pain Extracorporeal Shock Wave Therapy Device market expected to grow?
What does the Chronic Pain Extracorporeal Shock Wave Therapy Device market cover?
How is the Chronic Pain Extracorporeal Shock Wave Therapy Device market segmented by shock wave generation technology?
What are the key applications of Chronic Pain Extracorporeal Shock Wave Therapy Device?
Which companies are profiled in the Chronic Pain Extracorporeal Shock Wave Therapy Device market report?
What geographies does the Chronic Pain Extracorporeal Shock Wave Therapy Device market analysis include?
What are the key demand drivers for Chronic Pain Extracorporeal Shock Wave Therapy Device?
Who should buy the Chronic Pain Extracorporeal Shock Wave Therapy Device market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Chronic Pain Extracorporeal Shock Wave Therapy Device Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Healthcare & Medical Devices